Publications by authors named "Jill Bargonetti"

Claim this Profile
A
A cancer persistent DNA repair circuit driven by MDM2, MDM4 (MDMX), and mutant p53 for recruitment of MDC1 and 53BP1 on chromatin.
Viola Ellison, Alla Polotskaia, Gu Xiao, Pamella Leybengrub, Rusia Lee, Jill Bargonetti

Nucleic Acids Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipogenic enzyme FASN promotes mutant p53 accumulation and gain-of-function through palmitoylation.
Juan Liu, Yiyun Shen, Jie Liu, Dandan Xu, Chun-Yuan Chang, Jill Bargonetti

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine CXCL12 Activates CXC Receptor 4 Metastasis Signaling Through the Upregulation of a CXCL12/CXCR4/MDMX (MDM4) Axis.
Rusia Lee, Viola Ellison, Dominique Forbes, Chong Gao, Diana Katanov, Jill Bargonetti

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, John Nguyen, Rachel Martini, Jill Bargonetti

Cancer Lett· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53 suppresses MHC class II presentation by intestinal epithelium to protect against radiation-induced gastrointestinal syndrome.
Jianming Wang, Chun-Yuan Chang, Xue Yang, Fan Zhou, Juan Liu, Jill Bargonetti

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CANCER PERSISTENT DNA REPAIR CIRCUIT DRIVEN BY MDM2, MDM4 (MDMX), AND MUTANT P53 FOR RECRUITMENT OF MDC1 AND 53BP1 TO CHROMATIN.
Viola Ellison, Alla Polotskaia, Gu Xiao, Pamella Leybengrub, Weigang Qiu, Jill Bargonetti

bioRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, John Nguyen, Olufunmilayo I Olopade, Jill Bargonetti

bioRxiv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose.
Devon Lundine, George K Annor, Valery Chavez, Styliana Maimos, Zafar Syed, Jill Bargonetti

Mol Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant p53 Together with Gain-of-Function GLP-1/Notch Decreases UVC-Damage-Induced Germline Cell Death but Increases PARP Inhibitor-Induced Germline Cell Death.
Jorge Canar, Prima Manandhar-Sasaki, Jill Bargonetti

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status.
Rati Lama, Chao Xu, Samuel L Galster, Javier Querol-García, Scott Portwood, Jill Bargonetti

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities.
George K Annor, Nour Elshabassy, Devon Lundine, Don-Gerard Conde, Gu Xiao, Jill Bargonetti

Front Cell Dev Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models.
Thomas Wilson, Giacomo Pirovano, Gu Xiao, Zachary Samuels, Sheryl Roberts, Jill Bargonetti

Mol Pharm· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity.
Viola Ellison, George K Annor, Clara Freedman, Gu Xiao, Devon Lundine, Jill Bargonetti

Oncotarget· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.
Gu Xiao, George K Annor, Kimberly Fung, Outi Keinänen, Brian M Zeglis, Jill Bargonetti

Mol Pharm· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2-C Functions as an E3 Ubiquitin Ligase.
Jun Yeob Kim, Rusia Lee, Gu Xiao, Dominique Forbes, Jill Bargonetti

Cancer Manag Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Protein in the Yeast Presents DNA Binding Homology to the p53 Checkpoint Protein and Tumor Suppressor.
Kanwal Farooqi, Marjan Ghazvini, Leah D Pride, Louis Mazzella, David White, Jill Bargonetti

Biomolecules· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Gu Xiao, Devon Lundine, George K Annor, Jorge Canar, Viola Ellison, Jill Bargonetti

Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis.
Chong Gao, Gu Xiao, Jill Bargonetti

Oncotarget· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain-of-function mutant p53: history and speculation.
Jill Bargonetti, Carol Prives

J Mol Cell Biol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population.
Lenora W M Loo, Chong Gao, Yurii B Shvetsov, Danielle R Okoro, Brenda Y Hernandez, Jill Bargonetti

Breast Cancer Res Treat· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
Chong Gao, Gu Xiao, Alessandra Piersigilli, Jiangtao Gou, Olorunseun Ogunwobi, Jill Bargonetti

Breast Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
Nandini Kundu, Angelika Brekman, Jun Yeob Kim, Gu Xiao, Chong Gao, Jill Bargonetti

Oncotarget· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer.
Wei-Gang Qiu, Alla Polotskaia, Gu Xiao, Lia Di, Yuhan Zhao, Jill Bargonetti

NPJ Breast Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient.
Nataly Shtraizent, Hiroshi Matsui, Alla Polotskaia, Jill Bargonetti

Int J Environ Res Public Health· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death.
Melissa Rosso, Alla Polotskaia, Jill Bargonetti

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis